Clinical Marker of Platelet Hyperreactivity in Diabetes Mellitus
Diabetes & Metabolism Journal
;
: 423-428, 2013.
Artículo
en Inglés
| WPRIM
| ID: wpr-31448
ABSTRACT
Atherothrombotic complications are important causes of morbidity and mortality in diabetic patients. Diabetes has been considered to be a prothrombotic status. Several factors contribute to the prothrombotic condition, such as increasing coagulation, impaired fibrinolysis, endothelial dysfunction, and platelet hyperreactivity. Among the factors that contribute to the prothrombotic status in diabetes, altered platelet function plays a crucial role. Although understanding platelet function abnormalities in diabetes still remains as a challenge, more attention should be focused on platelet function for effective management and the prediction of atherothrombotic events in diabetic patients. This review will provide an overview on the current status of knowledge of platelet function abnormalities and clinical marker of platelet hyperreactivity in patients with diabetes.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Plaquetas
/
Biomarcadores
/
Mortalidad
/
Diabetes Mellitus
/
Fibrinólisis
Tipo de estudio:
Estudio pronóstico
Límite:
Humanos
Idioma:
Inglés
Revista:
Diabetes & Metabolism Journal
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS